Q13451 (FKBP5_HUMAN) Homo sapiens (Human)

Peptidyl-prolyl cis-trans isomerase FKBP5 UniProtKBInterProSTRINGInteractive Modelling

457 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

85 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human FKBP51 protein in complex with C-terminal peptide of Human HSP 90-alpha
5njx
 Heteromer
Q96HX7; 		13-425
3×SO4;
Assess
Cryo-EM structure of Hsp90:FKBP51:p23 closed-state complex
7l7i
 Heteromer
P07900; Q15185; 		13-421
2×ANP;
Assess
Cryo-EM structure of the GR-Hsp90-FKBP51 complex
8ffw
 Heteromer
P04150; P07900; 		13-421
2×ATP; 2×MG; 1×DEX;
Assess
Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR at low …
4drh
 Heteromer
P42345; 		9-140
1×RAP; 11×SO4;
Assess
Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR
4dri
 Heteromer
P42345; 		20-140
1×RAP;
Assess
SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC
8pc2
 Heteromer
P40337; Q15369; Q15370; 		21-140
1×XZW;
Assess
The Fk1 domain of FKBP51 in complex with (2S)-2-((1S,5R,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo…
7aps
homo-2-mer16-140
2×RR5;
Assess
Human FKBP5 protein
5omp
monomer13-424
3×SO4;
Assess
Structure of the Large FKBP-like Protein, FKBP51, Involved in Steroid Receptor Complexes
1kt0
monomer33-412
3×SO4;
Assess
Crystal structure of a fragment of FKBP51 comprising the Fk1 and Fk2 domains
3o5d
monomer13-254
Assess
Fk1 domain of FKBP51, crystal form VI
3o5e
monomer13-140
Assess
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet…
7apw
monomer16-140
1×RSB;
Assess
Fk1 domain mutant A19T of FKBP51, crystal form IV, in presence of DMSO
3o5q
monomer16-140
2×DMS;
Assess
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH NICOTINAMIDE
6tx6
monomer16-140
1×CL; 2×NA; 2×NCA;
Assess
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p…
8chn
monomer16-140
1×UUI;
Assess
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfinyl)-3-(pyridi…
8chp
monomer16-140
1×UT6;
Assess
Exploration of Pipecolate Sulfonamides as Binders of the FK506-Binding Proteins 51 and 52: Complex …
4drq
monomer16-140
1×0OS;
Assess
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-5-(hydroxymet…
5obk
monomer16-140
1×9QN;
Assess
Fk1 domain mutant A19T of FKBP51, crystal form IV
3o5p
monomer16-140
Assess
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …
4jfm
monomer16-140
1×1KZ;
Assess
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-(2-methoxye…
4tx0
monomer16-140
1×384;
Assess
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PYRIDONE
6tx4
monomer16-140
1×CL; 2×NA; 2×HRZ;
Assess
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[…
4drn
monomer16-140
1×0MC;
Assess
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …
4jfj
monomer16-140
1×1KU;
Assess
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-3-[2-(3,4-dim…
4w9q
monomer16-140
1×3JP;
Assess
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 4-METHYLIMIDAZOLE
6tx5
monomer16-140
2×NA; 1×4MZ;
Assess
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet…
7apq
monomer16-140
1×RQW;
Assess
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((R)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p…
8chr
monomer16-140
1×UUI;
Assess
Structure of the FK1 domain of the FKBP51 G64S variant in complex with (2R,5S,12R)-12-cyclohexyl-2-…
8ba6
monomer16-140
1×S8N;
Assess
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH (1R)…
4dro
monomer16-140
1×0MD;
Assess
Structure of the FK1 domain of the FKBP51 G64S variant in complex with SAFit1
7r0l
monomer16-140
1×GY1; 1×EPE; 2×GOL;
Assess
Complex of Fk506 with the Fk1 domain mutant A19T of FKBP51
3o5r
monomer16-140
1×FK5;
Assess
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PIPERIDONE
6tx7
monomer16-140
1×CL; 2×NA; 2×V1L;
Assess
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 63
7ba0
monomer16-140
1×T5H;
Assess
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …
4jfk
monomer16-140
1×JFK;
Assess
Fk1 domain mutant A19T of FKBP51, crystal form III
3o5o
monomer16-140
1×SCN;
Assess
The Fk1 domain of FKBP51 in complex with (2'R,5'S,12'R)-12'-cyclohexyl-2'-[2-(3,4-dimethoxyphenyl)e…
7aou
monomer16-140
1×RTT;
Assess
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …
4jfl
monomer16-140
1×1KY;
Assess
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH IMIDAZOLE
6tx8
monomer16-140
1×CL; 2×NA; 1×IMD;
Assess
The Fk1 domain of FKBP51 in complex with iFit4
4tw7
monomer16-140
1×37K;
Assess
The Fk1 domain of FKBP51 in complex with the new synthetic ligand 2-(3-((R)-1-((S)-1-((S)-2-cyclohe…
5diu
monomer16-140
1×5BG;
Assess
Fk1 domain mutant A19T of FKBP51, crystal form I
3o5l
monomer16-140
1×1PE;
Assess
The FK1 domain of FKBP51 in complex with peptide-inhibitor hit DFPFV
7etv
monomer16-140
Assess
The Fk1 domain of FKBP51 in complex with SAFit1
8cca
monomer16-140
1×GY1;
Assess
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 64a
7b9y
monomer16-140
1×T5B;
Assess
The Fk1 domain of FKBP51 in complex with iFit1
4tw6
monomer16-140
1×37L; 1×GOL; 1×NA;
Assess
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH HYDANTOIN
6tx9
monomer16-140
1×HYN; 2×NA;
Assess
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 35-(E)
7b9z
monomer16-140
1×T58; 3×IS8;
Assess
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[…
4drm
monomer16-140
1×0MC;
Assess
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[…
4drk
monomer16-140
1×I63;
Assess
FKBP51FK1 F67E/K60Orn (i, i+7) in complex with SAFit1
8pj8
monomer16-140
1×GY1;
Assess
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)propanoy…
8ccc
monomer16-140
1×UCT;
Assess
FKBP51FK1 F67E/K58 (i, i+9) in complex with SAFit1
8pja
monomer16-140
1×GY1;
Assess
Fk1 domain of FKBP51, crystal form VII
3o5f
monomer15-139
1×CO3;
Assess
The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-(5-chlorothiophen-2-yl)-2-cyclohe…
8ccb
monomer16-140
1×U83;
Assess
The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-cyclohexyl-2-(thiophen-2-yl)acety…
8cch
monomer16-140
1×U8C;
Assess
Evaluation of Synthetic FK506 Analogs as Ligands for the FK506-Binding Proteins 51 and 52: Complex …
4drp
monomer16-140
1×0MD;
Assess
Fk1 domain of FKBP51, crystal form II
3o5i
monomer16-140
Assess
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 33-(Z)
7a6w
monomer16-140
1×R3E;
Assess
Fk1 domain of FKBP51, crystal form I
3o5g
monomer16-140
Assess
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)pent-4-e…
8ccf
monomer16-140
1×UC0;
Assess
The Fk1 domain of FKBP51 in complex with (S)-(R)-3-(3,4-dimethoxyphenyl)-1-(3-(2-morpholinoethoxy)p…
6saf
monomer16-140
1×L2Q;
Assess
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)-2-(3,4,…
8ccd
monomer16-140
1×UCO;
Assess
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH SAFit2
6txx
monomer16-140
1×37K;
Assess
The Fk1 domain of FKBP51 in complex with the new synthetic ligand (1R)-3-(3,4-dimethoxyphenyl)-1-f3…
5dit
monomer16-140
1×5B8;
Assess
The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]…
7aot
monomer16-139
1×RTQ;
Assess
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-3,5-dichloro-N-methylphenylsulfonimidoy…
8chq
monomer16-139
1×UMR;
Assess
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …
4jfi
monomer16-139
1×1KT; 1×DMS; 1×GOL;
Assess
The Fk1 domain of FKBP51 in complex with ((1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-viny…
7apt
monomer16-139
1×RRZ;
Assess
Structure of the FK1 domain of the FKBP51 G64S variant in complex with (1S,5S,6R)-10-((3,5-dichloro…
8baj
monomer16-139
1×9QN;
Assess
Complex of the Fk1 domain mutant A19T of FKBP51 with 4-Nitrophenol
5bxj
monomer16-139
1×NPO;
Assess
The Fk1 domain of FKBP51 in complex with (2R,5S,12S)-12-(thiophen-2-yl)-2-[2-(3,4-dimethoxyphenyl)e…
8ccg
monomer16-139
1×UBK;
Assess
The FK1 domain of FKBP51 in complex with peptide-inhibitor hit SFPFT
7etu
monomer16-139
Assess
The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]…
7awf
monomer16-139
1×S8N;
Assess
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)butanoyl…
8cce
monomer16-139
1×UCF; 1×GOL;
Assess
The FK1 domain of FKBP51 in complex with peptide-inhibitor hit QFPFV
7ett
monomer16-139
Assess
Fk1 domain mutant A19T of FKBP51, crystal form II
3o5m
monomer16-139
Assess
The Fk1 domain of FKBP51 in complex with the new synthetic ligand (S)-N-(1-carbamoylcyclopentyl)-1-…
5div
monomer16-139
1×5BH;
Assess
Fk1 domain of FKBP51, crystal form III
3o5j
monomer16-139
Assess
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 55
7awx
monomer16-139
1×S5W;
Assess
Fk1 domain of FKBP51, crystal form VIII
3o5k
monomer16-139
Assess
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1R)-1,2-d…
4w9o
monomer17-139
1×3JQ;
Assess
Allosteric coupling of conformational transitions in the FK1 domain of FKBP51 near the site of ster…
4r0x
monomer20-140
Assess
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1S)-1,2-d…
4w9p
monomer19-139
1×3JR;
Assess
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 56
7a6x
monomer22-139
1×R3B;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5omp.1.Amonomer0.8013-424
100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23o5d.1.Amonomer0.7713-234
95.28
Assess